Steven Artandi, MD, PhD

1.8K posts

Steven Artandi, MD, PhD banner
Steven Artandi, MD, PhD

Steven Artandi, MD, PhD

@SCIDirector

Stanford University medical oncologist and cancer scientist, and Director of the Stanford Cancer Institute. Follows and retweets are not endorsements.

Stanford, CA Katılım Kasım 2018
1.6K Takip Edilen3.9K Takipçiler
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
Applications are now open for the Stanford Cancer Institute Innovation Awards, which support bold, collaborative cancer research. I encourage you to apply. brnw.ch/21x0MFZ
English
0
2
4
397
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
Sri Seshadri’s legacy is one of collaboration, compassion, and innovation. He united diverse fields to create a cancer care system rooted in inclusion and responsibility. His absence will be deeply felt by all who worked with him. brnw.ch/21x0Erq
Steven Artandi, MD, PhD tweet media
English
0
0
4
365
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member Claudia Petritsch & others built a high-resolution atlas of #Glioblastoma, mapping how malignant, vascular & immune cells are organized. They reveal new vascular cell states & a core oligodendrocyte population tied to recurrence & poor outcomes. brnw.ch/21x0ArJ
English
0
0
5
470
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member @aliceyting & team developed Conformational Biasing, a fast method for predicting protein variants biased toward specific conformations. CB reveals novel mechanisms, enhances protein functions, and has broad applications in research & medicine.brnw.ch/21x0scv
Steven Artandi, MD, PhD tweet media
English
0
0
0
382
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member @leahbackhusmd & others developed a novel framework to examine post-treatment surveillance for #NSCLC. Their study revealed lower-than-expected guideline-concordant surveillance rates among veterans, highlighting a gap in care. brnw.ch/21x0fTj
Steven Artandi, MD, PhD tweet media
English
0
0
4
361
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member Ali Khaki & others show survey data clarify real-world mUC treatment choices, with clinicians favoring EVP first line after prior ICI and non-ICI strategies after progression. brnw.ch/21x0bN7 #BladderCancer
Steven Artandi, MD, PhD tweet media
English
0
0
6
481
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
@HwakeleeMD and I are pleased to announce that @VivekSubbiah has been appointed as the @StanfordCancer inaugural associate director for drug development and precision oncology. He will lead our Early Drug Development Program, focusing on phase 1 clinical trials and rare cancers.
Steven Artandi, MD, PhD tweet media
English
0
2
44
5K
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member Manali Patel & others found a simple phone-based symptom assessment intervention, led by lay health workers, reduced emergency department visits by more than 1/2 and hospitalizations by2/3s among older adults with cancer. brnw.ch/21x07Oo
Steven Artandi, MD, PhD tweet media
English
0
0
2
266
Steven Artandi, MD, PhD
Steven Artandi, MD, PhD@SCIDirector·
SCI member Antonio Omuro & others found R-MPV-A highly effective for primary #CNSLymphoma; adding low-dose whole-brain RT improved progression-free survival without worsened cognition. brnw.ch/21wZN2X
Steven Artandi, MD, PhD tweet media
English
0
0
0
244